AU2022901811A0 - New treatment for neurodegenerative diseases - Google Patents

New treatment for neurodegenerative diseases

Info

Publication number
AU2022901811A0
AU2022901811A0 AU2022901811A AU2022901811A AU2022901811A0 AU 2022901811 A0 AU2022901811 A0 AU 2022901811A0 AU 2022901811 A AU2022901811 A AU 2022901811A AU 2022901811 A AU2022901811 A AU 2022901811A AU 2022901811 A0 AU2022901811 A0 AU 2022901811A0
Authority
AU
Australia
Prior art keywords
neurodegenerative diseases
new treatment
treatment
new
neurodegenerative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022901811A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genieus Genomics Pty Ltd
Original Assignee
Genieus Genomics Pty Ltd
Filing date
Publication date
Application filed by Genieus Genomics Pty Ltd filed Critical Genieus Genomics Pty Ltd
Publication of AU2022901811A0 publication Critical patent/AU2022901811A0/en
Pending legal-status Critical Current

Links

AU2022901811A 2022-06-29 New treatment for neurodegenerative diseases Pending AU2022901811A0 (en)

Publications (1)

Publication Number Publication Date
AU2022901811A0 true AU2022901811A0 (en) 2022-07-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP3986392A4 (en) Compounds for treatment of pd-l1 diseases
EP3908374A4 (en) Compositions and methods for diagnosis and treatment of neurodegenerative diseases
EP3773629A4 (en) Car-treg-based therapies for treating neurodegenerative diseases
EP3934646A4 (en) Pharmaceutical compositions for treating ocular diseases or disorders
EP3685840A4 (en) Compound pharmaceutical composition for treating inflammatory skin diseases
EP4017490A4 (en) Compounds and methods for treating oxalate-related diseases
EP3954368A4 (en) Compound for treating neurodegenerative disorders
AU2022901811A0 (en) New treatment for neurodegenerative diseases
AU2021901964A0 (en) New treatment for neurodegenerative diseases
AU2020902218A0 (en) New treatment for neurodegenerative diseases
EP3909568A4 (en) Prophylactic or therapeutic drug for neurodegenerative diseases
EP4010326A4 (en) Kinase inhibitors for the treatment of neurodegenerative diseases
EP3946414A4 (en) Method for treating ocular diseases
EP3903806A4 (en) Pharmaceutical composition for treating trpv1 activity-mediated diseases
EP4096783A4 (en) Compositions for hemorrhoid treatment
EP3846816A4 (en) Neuroprotective agents for treatment of neurodegenerative diseases
EP3936124A4 (en) Pharmaceutical composition for preventing or treating neurological diseases
EP3940384A4 (en) Method for screening compound for treating or preventing polyq-related neurodegenerative diseases
TWI844080B (en) Methods of treating neurodegenerative diseases
EP3976034A4 (en) A composition for treating eye diseases
EP3866795A4 (en) Treatment of neurological diseases
AU2022283443A1 (en) Compounds for treating genetic diseases
AU2022296903A1 (en) Treatment for autoimmune diseases
EP3946266A4 (en) Sumo peptides for treating neurodegenerative diseases
AU2024900640A0 (en) Treatment methods for muscle-associated diseases